Cartiva competitorsClear all
Fusion Antibodies's top competitors include Tissue Regenix Group, Orthofix and Affymetrix.
| Save Comparison |  Fusion Antibodies Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization. |  Tissue Regenix Group Tissue Regenix uses its patented dCELL technology to address many clinical needs such as sports medicine, wound care and heart valve replacement. |  Orthofix Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. |  Affymetrix Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level. |
Founding Date | Founding Date 2001 | Founding Date 2006 | Founding Date 1980 | Founding Date 1994 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Belfast, GB HQ | Locations Swillington, GB HQ San Antonio, US | ||
Employees | Employees 398% increase | Employees 61 | Employees 1,05511% increase | Employees 7491% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 49.6 m | Valuation ($) 861.5 m | Valuation ($) N/A |
Twitter followers | Twitter followers 1.1 k | Twitter followers 885 | Twitter followers N/A | Twitter followers 3 |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 461736 | Alexa Website Rank 198945 | Alexa Website Rank N/A |
Employee Rating | Employee Rating N/A | Employee Rating 1.7 | Employee Rating 2.7 | Employee Rating N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) £2.2m (FY, 2019) | Revenue (est.) £11.6m (FY, 2018) | Revenue (est.) $460m (FY, 2019) | Revenue (est.) $359.8m (FY, 2015) |
Cost of goods | Cost of goods £1.4m (FY, 2019) | Cost of goods £5.7m (FY, 2018) | Cost of goods $100.6m (FY, 2019) | Cost of goods $110.8m (FY, 2015) |
Gross profit | Gross profit £804k (FY, 2019) | Gross profit £5.9m (FY, 2018) | Gross profit $359.3m (FY, 2019) | Gross profit $249m (FY, 2015) |
Net income | Net income (£1.3m) (FY, 2019) | Net income (£8.3m) (FY, 2018) | Net income ($28.5m) (FY, 2019) | Net income $10.1m (FY, 2015) |
For sources of this data, please see the company profile
View company profiles
Tissue Regenix Group
HQ
Swillington, GB
Employees
61
Tissue Regenix uses its patented dCELL technology to address many clinical needs such as sports medicine, wound care and heart valve replacement.
View companyOrthofix
HQ
Z.a.i., IT
Employees
1,055↑ 11% increase
Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.
View companyAffymetrix
HQ
Santa Clara, US
Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level.
View company